BPAP
BPAP (Benzofuranylpropylaminopentane) is a highly specialized synthetic research compound belonging to the unique class of monoaminergic activity enhancers (MAEs). Structurally related to trace amine derivatives, BPAP is extensively investigated in neurochemical research settings for its ability to modulate neurotransmitter transport mechanics. Unlike classical monoamine releasing agents, literature indicates that BPAP enhances impulse-evoked amine release without dumping baseline neurotransmitter pools directly. It serves as a vital benchmark compound in controlled laboratory models exploring ligand-receptor interactions, competitive transport inhibition, and neurotransmitter system dynamics.
Technical Specifications
| Property | Specification |
| Product Name | BPAP (Benzofuranylpropylaminopentane) |
| CAS Number | 260550-89-8 |
| IUPAC Name | (2R)-1-(1-benzofuran-2-yl)-N-propylpentan-2-amine |
| Molecular Formula | C₁₆H₂₃NO |
| Molecular Weight | 245.36 g/mol |
| Chemical Class | Benzofuran derivative / Monoaminergic Activity Enhancer (MAE) |
| Assay Purity | Check batch COAs |
| Solution Base | PEG400, DMSO |
Research Applications & Mechanism of Interest
In laboratory science, BPAP provides an exceptional core framework for evaluating non-classical neuromodulation pathways. Its primary mechanism of interest centers on its targeted interactions with amine transport systems in isolated testing environments.
Primary fields of investigative research include:
-
Amine Transport Dynamics: Studying how the specific configuration of the benzofuran ring and its appended propylpentan-2-amine functional group influences ligand binding behaviors at dopamine, norepinephrine, and serotonin transporters.
-
Competitive Inhibition Profiles: Utilizing the molecule in cell-free binding assays to evaluate competitive displacement against labeled compounds, mapping out transporter-ligand affinity thresholds.
-
Bimodal Concentration-Response Modeling: Researchers utilize BPAP to analyze how varying concentrations of the molecule impact baseline cellular signaling networks and neurotransmitter responsiveness in closed in vitro systems.
-
Structure-Activity Relationship (SAR) Studies: Benchmarking BPAP against legacy monoamine modulators and endogenous trace amines to track molecular footprints, structural stability, and degradation patterns.
Storage & Handling Guidelines
Store at controlled room temperature. Keep tightly closed. Liquid formats: do not refrigerate or freeze. Cold storage may cause the solution to cloud or precipitate. If this occurs, return to room temperature and mix until clear.
Storage guidance is a house recommendation. Analytical documentation is per-lot release testing.
Related Research Compounds
Further reading: BPAP research overview
Frequently Asked Research Questions
How does BPAP differ from classical stimulants like amphetamines?
While both classes influence neurotransmitter levels, amphetamines cause neurons to dump their neurotransmitter stores uncontrollably into the synapse. BPAP is a selective activity enhancer that does not cause random release; instead, it only amplifies the amount of neurotransmitter released when a neuron naturally receives an electrical impulse.
What is the significance of BPAP’s bimodal concentration-response relationship?
In preclinical models, BPAP exhibits two distinct, bell-shaped curves of activity depending on the concentration range tested. This complex pharmacodynamic behavior makes it a highly valued compound for studying narrow, non-linear activation windows.
Scientific References
-
Knoll, J., Yoneda, F., Knoll, B., Ohde, H., & Miklya, I. (1999). “(-)1-Benzofuran-2-yl)-2-propylaminopentane [(-)BPAP], a selective enhancer of the impulse propagation mediated release of catecholamines and serotonin in the rat brain.” British Journal of Pharmacology, 128(8), 1723–1732. doi:10.1038/sj.bjp.0702995.
-
Miklya, I., & Knoll, J. (2003). “Analysis of the effect of (-)BPAP, a selective enhancer of the impulse propagation-mediated release of catecholamines and serotonin in the brain.” Life Sciences, 72(25), 2915–2921. doi:10.1016/s0024-3205(03)00197-8.
-
Shimazu, S., Miklya, I., et al. (2003). “Enhancer substances: selegiline and R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane [(-)-BPAP] enhance the neurotrophic factor synthesis on cultured mouse astrocytes.” Life Sciences, 72(24), 2785–2792. doi:10.1016/s0024-3205(03)00191-7.
Research Use Only Disclaimer: This product is distributed and sold strictly as a Research Use Only (RUO) compound. It is not a drug, licensed medication, or dietary supplement, and is strictly prohibited for human or veterinary consumption. Kimera Chems supplies these materials exclusively to qualified scientific institutions and professional investigators for use within controlled in vitro laboratory frameworks.
